Retrospective Evaluation of the Results of Low-Dose Intravenous Thrombolytic Therapy in Acute Ischemic Stroke

Creative Commons License

ÇETİNER M., Eskut N., AKDAĞ G., Arikan F. A., Guler M., Kabay S.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, cilt.57, sa.3, ss.359-366, 2023 (ESCI, TRDizin)

Özet

Objectives: This study aimed to investigate the clinical data of patients with acute ischemic stroke who received low-dose intra-venous (IV) thrombolytic therapy (0.9 mg/kg; maximum 50 mg) for various reasons, compare the obtained results with those of patients who received standard-dose thrombolytic therapy, and discuss them in light of the literature. Methods: Patients who received IV thrombolytic therapy within 4.5 h of symptom onset between January 2015 and June 2018 were retrospectively reviewed. Patients were divided into the low-dose group (0.9 mg/kg; max. 50 mg) and the standard-dose group (0.9 mg/kg; max 90 mg) according to the thrombolytic therapy dose, after which demographic data and clinical results were analyzed. Results: A total of 109 patients receiving thrombolytic therapy (19 patients in the low-dose group and 90 patients in the stan-dard-dose group) were included in the study. There was no significant difference between the two groups in terms of good out-come rates (47.4% vs. 52.2%). There was no statistically significant difference in terms of symptomatic and asymptomatic intrace-rebral hemorrhage rates. Conclusion: Our study showed similar efficacy and safety for low-dose IV thrombolytic therapy compared with standard-dose IV thrombolytic therapy administered within 4.5 h of symptom onset in patients with acute ischemic stroke.